COMMUNIQUÉS West-GlobeNewswire

Ignitus Recovery Announces Acquisition of AIM Health: Building on a 20-Year Legacy
16/09/2026
BOULDER, Colo., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Ignitus Recovery is proud to announce the acquisition of AIM Health Boulder, a respected behavioral health program serving young adults, individuals, and families in [...]
TwitchView® Selected by Two Additional Top 10 U.S. Children's Hospitals for Quantitative Neuromuscular Monitoring
16/09/2026
SEATTLE, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Blink Anesthesia announced today that two of the top 10 largest children's hospitals in the United States have selected the TwitchView® Train of Four Monitor as their [...]
NADP Foundation Issues Request for Proposals
16/09/2026
DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) Foundation is pleased to issue its 2027 request for proposal (RFP) with the objective of supporting innovative projects that [...]
Horse Peak Gelatin Launch 2026: Natural Vitality Formula For Men Read HorsePeak Gummies Supplement Facts & Ingredients Highlights
16/09/2026
Discover Horse Peak Gelatin Gummies 2026 and explore the natural vitality formula, supplement facts, key ingredients, potential benefits, serving details, and everything you should know before choosing this men's [...]
Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial
16/09/2026
LONDON and PHILADELPHIA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, announces today that it has achieved clinical proof of [...]
TerrAscend Strengthens Leadership Position in New Jersey with Closing of Aunt Mary’s Transaction
16/09/2026
Expands New Jersey retail footprint to five dispensaries Dispensary generates over US$10 million in annualized revenue and will be immediately accretive to EBITDA and cash flow TORONTO, Sept. 16, 2026 (GLOBE NEWSWIRE [...]
Dr. Peter Goldman Returns to the Bay Area, Bringing Zone Technique and a Distinct Approach to Healing to Berkeley, CA
16/09/2026
Founder of Zone School of Healing Uses the Zone Technique to Balance the Body’s Six Main Systems, Helping Clients Pursue Healing at the Highest Level BERKELEY, CA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- After nearly a [...]
X-Chem Named First Winner of Chordoma Foundation TBXT Challenge with Discovery of Novel Binder for Untreatable Bone Cancer Target
16/09/2026
Groundbreaking synergy of DEL screening and computational chemistry yields the first compound to meet the TBXT Challenge’s submicromolar binding threshold for brachyury (TBXT) WALTHAM, Mass., Sept. 16, 2026 (GLOBE [...]
NEXGEL Announces Date for Investor Update Call
16/09/2026
LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians [...]
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
16/09/2026
MINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc. ("PetVivo"), in cooperation with its parent, PetVivo Holdings, Inc. (OTCQX: PETV), and its other subsidiaries, Somatrix Technologies, Inc. and [...]
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
16/09/2026
HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (NYSE: IBO) (the “ Company ” or “ Impact ”) announced that a Form F-4 registration statement (the “ Registration Statement ”) was filed with the U.S. [...]
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
16/09/2026
Total national coverage footprint for PENFS increases to over 120 million covered lives CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical [...]
NeuroSigma Expands Payment Options for the Monarch eTNS® System
16/09/2026
Families prescribed Monarch can now pay with digital wallets or third-party installment plans at checkout LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced expanded payment options for [...]
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
16/09/2026
Collaboration with leading 22-location interventional pain practice supports Milestone’s longer-term reimbursement strategy ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: [...]
Gautham Chidambaram Announces New QP & Half-Pound THCA Flower Sizing at Passion Farms
16/09/2026
Passion Farms just made it easier for wholesale buyers to try new strains-rolling out QP and half-pound THCA flower sizes across TX, CA & OK, no more pound minimums. HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- [...]
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
16/09/2026
DENVER, Sept. 16, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) executives put even more personal capital behind the company, following positive Phase 2a results for its [...]
Major shareholder announcement - BlackRock, Inc.
16/09/2026
16 September 2026 ANNOUNCEMENT NO. 315 Major shareholder announcement - BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that [...]
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
16/09/2026
LA JOLLA, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that [...]
Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.
16/09/2026
New Preclinical PDAC Data for PRP Show >90% Tumor-Growth Inhibition & >2.5-Fold Survival Benefit; Company Highlights How Reversing Epithelial-Mesenchymal Transition May Deepen & Extend Responses to RAS(ON [...]

Pages